| Identification | |
| Name: | Imidodicarbonimidicdiamide, N-butyl- |
| Synonyms: | Biguanide,1-butyl- (6CI,8CI); 1-Butylbiguanide; Buformin; Buformine; Butformin;Butylbiguanide; Butyldiguanide; DBV; Dibetos B; Glybigid; H 224;N1-Butylbiguanide; W 37 |
| CAS: | 692-13-7 |
| EINECS: | 211-726-4 |
| Molecular Formula: | C6H15 N5 |
| Molecular Weight: | 157.26 |
| InChI: | InChI=1/C6H15N5/c1-2-3-4-10-6(9)11-5(7)8/h2-4H2,1H3,(H6,7,8,9,10,11) |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 148.9°C |
| Boiling Point: | 322.7°C at 760 mmHg |
| Density: | 1.22g/cm3 |
| Refractive index: | 1.568 |
| Specification: |
Buformin [USAN:INN] (CAS NO.692-13-7) is an oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation. |
| Flash Point: | 148.9°C |
| Usage: |
Buformin [USAN:INN] (CAS NO.692-13-7) , clinically used for diabetes mellitus, is known to improve resistance to insulin in patients. It suppresses the expression of glyceraldehyde 3-phosphate dehydrogenase. |
| Safety Data | |
 |
|
